• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

Q&A with Nancy T. Chang, Ph.D., plenary speaker for the fifth annual Innovation and Commercialization Conference

Posted on September 14, 2020 by Steve Martin

Nancy T. Chang, Ph.D., founded Tanox, a biopharmaceutical company, in 1986 while on faculty at the Baylor College of Medicine. The company developed Xolair, an anti-inflammatory asthma treatment, that the U.S. Food and Drug Administration approved for use in 2003. Tanox was acquired by Genentech in 2007 for $919 million.

Nancy T. Chang

Chang will speak during the Sept. 17 plenary session of the two-day Indiana University Innovation and Commercialization Conference. She will provide her perspective about developing research from her laboratory into a multibillion-dollar enterprise. She generously shared her time to answer a few questions about her success.

Crimson Catalyst: What were the origins of your interest in research on allergies and HIV?

Nancy T. Chang: My family has always suffered from allergies. Growing up, we had a very hard time dealing with them, and there wasn’t anything on the market that was helpful for us. Regarding HIV, it began with scientific curiosity — and then the AIDS pandemic broke out and was running rampant through the country, so I wanted to help those who were being hurt by the horrible disease.

CC: How would you describe the process of commercializing your research into Xolair?

NTC: It was very exciting! Seeing lab work turn into a commercially viable drug is an amazing experience. Seeing your idea prove itself as something that makes people’s lives better is the best feeling.

CC: You founded Tanox in 1986; Xolair was approved by the U.S. FDA in June 2003. What are your strongest memories or emotions of that 17-year span?

NTC: I remember the excitement I felt when I first saw the data come back that showed our drug was working in patients. I will never forget that day.

CC: How has the world of research translation and commercialization changed since your experiences with Xolair and Tanox?

NTC: The speed with which we communicate and technological advancements have really helped speed up the process.

CC: You also have a strong background as an angel investor. What do you see as the most important lesson entrepreneurs must master in order to successfully interest an angel investor?

NTC: Young entrepreneurs need to be able to explain their story to nonscientists in a way that they can understand and that excites them. Entrepreneurs also need to know their data inside and out.

CC: What are your hopes for the future of biopharmaceuticals?

NTC: To see new breakthroughs that cure diseases that are currently untreatable. Cancer and Alzheimer’s are a couple for which I think we are going to see some major breakthroughs soon.

Register for the fifth annual Innovation and Commercialization Conference online.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: Entrepreneurship, IU Innovation and Commercialization Office, Technology Commercialization

One Comment

  1. yen hua shih November 1st, 2020

    school mate ,yen

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President of Government Relations and Economic Engagement.

Subscribe to the Innovate Indiana Blog

Sign up to receive regular updates from Innovate Indiana Blog

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

About the Authors

Ryan Piurek
Tony Armstrong
Joe Carley
David Gard
Bill Stephan
Kirk White
Teri Willey

Archives by Year

2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

Categories

  • Alumni
  • Defense Partnerships
  • Economic Development
  • Engagement
  • Entrepreneurship
  • Faculty
  • International Engagement
  • IU Innovation and Commercialization Office
  • IU Regional Campuses
  • IU Research & Technology Corporation
  • IU Ventures
  • Research
  • Staff
  • Statewide Engagement
  • Students
  • Technology Commercialization
  • Uncategorized
  • Workforce Development

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Grand Challenges
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Government Relations and Economic Engagement
  • IU Ventures

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.